Es gab 50 kürzliche Insider-Transaktionen für PDS Biotechnology Corporation (PDSB), darunter 47 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $9.26M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Brawley Otis W, Glover Stephen C., Boesgaard Lars. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PDSB
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-12 |
Brawley Otis W |
Director |
RSU-Zuteilung |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Glover Stephen C. |
Director |
RSU-Zuteilung |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Boesgaard Lars |
Chief Financial Officer |
RSU-Zuteilung |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Freitag Gregory Gene |
Director |
RSU-Zuteilung |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Ali-jackson Kamil |
Director |
RSU-Zuteilung |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Toutain Stephan |
Chief Operating Officer |
RSU-Zuteilung |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Conn Gregory |
Chief Scientific Officer |
RSU-Zuteilung |
150,000 |
$0.98 |
$147K |
150,000 |
| 2026-01-12 |
Bedu-addo Frank |
President/ceo |
RSU-Zuteilung |
548,782 |
$0.98 |
$537.81K |
548,782 |
| 2026-01-12 |
Iliev Ilian |
Director |
RSU-Zuteilung |
54,876 |
$0.98 |
$53.78K |
54,876 |
| 2026-01-12 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU-Zuteilung |
300,000 |
$0.98 |
$294K |
300,000 |
| 2026-01-12 |
Shepard Kirk V. |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
$0.98 |
$294K |
300,000 |
| 2025-06-12 |
Boesgaard Lars |
Chief Financial Officer |
RSU-Zuteilung |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Toutain Stephan |
Chief Operations Officer |
RSU-Zuteilung |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Conn Gregory |
Chief Scientific Officer |
RSU-Zuteilung |
40,000 |
$1.79 |
$71.6K |
40,000 |
| 2025-06-12 |
Bedu-addo Frank |
President/ceo |
RSU-Zuteilung |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU-Zuteilung |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-12 |
Shepard Kirk V. |
Chief Medical Officer |
RSU-Zuteilung |
150,000 |
$1.79 |
$268.5K |
150,000 |
| 2025-06-11 |
Brawley Otis W |
Director |
RSU-Zuteilung |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Glover Stephen C. |
Director |
RSU-Zuteilung |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Freitag Gregory Gene |
Director |
RSU-Zuteilung |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Ali-jackson Kamil |
Director |
RSU-Zuteilung |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-06-11 |
Iliev Ilian |
Director |
RSU-Zuteilung |
22,700 |
$1.75 |
$39.73K |
22,700 |
| 2025-02-28 |
Glover Stephen C. |
Director |
Informierter Kauf |
15,061 |
$1.53 |
$23.04K |
15,061 |
| 2025-02-28 |
Freitag Gregory Gene |
Director |
Informierter Kauf |
15,060 |
$1.53 |
$23.04K |
15,060 |
| 2024-06-24 |
Brawley Otis W |
Director |
RSU-Zuteilung |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Glover Stephen C. |
Director |
RSU-Zuteilung |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Sykes Richard |
Director |
RSU-Zuteilung |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Freitag Gregory Gene |
Director |
RSU-Zuteilung |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Ali-jackson Kamil |
Director |
RSU-Zuteilung |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-06-24 |
Iliev Ilian |
Director |
RSU-Zuteilung |
9,000 |
$2.86 |
$25.74K |
9,000 |
| 2024-05-01 |
Toutain Stephan |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-05-01 |
Toutain Stephan |
Chief Operations Officer |
RSU-Zuteilung |
200,000 |
$3.61 |
$722K |
200,000 |
| 2024-02-28 |
Conn Gregory |
Chief Scientific Officer |
RSU-Zuteilung |
46,648 |
$5.87 |
$273.82K |
46,648 |
| 2024-02-28 |
Bedu-addo Frank |
President/ceo |
RSU-Zuteilung |
300,000 |
$5.87 |
$1.76M |
300,000 |
| 2024-02-28 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU-Zuteilung |
56,000 |
$5.87 |
$328.72K |
56,000 |
| 2024-01-22 |
Shepard Kirk V. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-01-22 |
Shepard Kirk V. |
Chief Medical Officer |
RSU-Zuteilung |
200,000 |
$4.49 |
$898K |
200,000 |
| 2023-12-04 |
Boesgaard Lars |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-04 |
Boesgaard Lars |
Chief Financial Officer |
RSU-Zuteilung |
200,000 |
$5.28 |
$1.06M |
200,000 |
| 2023-07-14 |
Brawley Otis W |
Director |
RSU-Zuteilung |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Glover Stephen C. |
Director |
RSU-Zuteilung |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Sykes Richard |
Director |
RSU-Zuteilung |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Freitag Gregory Gene |
Director |
RSU-Zuteilung |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Ali-jackson Kamil |
Director |
RSU-Zuteilung |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-07-14 |
Iliev Ilian |
Director |
RSU-Zuteilung |
9,000 |
$5.13 |
$46.17K |
9,000 |
| 2023-01-05 |
Hill Matthew C |
Chief Financial Officer |
RSU-Zuteilung |
161,200 |
- |
- |
161,200 |
| 2023-01-05 |
Wood Lauren |
Chief Medical Officer |
RSU-Zuteilung |
110,800 |
- |
- |
110,800 |
| 2023-01-05 |
Conn Gregory |
Chief Scientific Officer |
RSU-Zuteilung |
137,200 |
- |
- |
137,200 |
| 2023-01-05 |
Bedu-addo Frank |
President/ceo |
RSU-Zuteilung |
385,300 |
- |
- |
385,300 |
| 2023-01-05 |
Brown Spencer D. |
Senior VP, General Counsel |
RSU-Zuteilung |
20,400 |
- |
- |
20,400 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
